跳至主要内容
临床试验/CTRI/2021/11/037840
CTRI/2021/11/037840尚未招募1/2 期

EFFECT OF KSHOUDRADI ASCHYOTANA IN ARJUNA w.s.r.t SUB-CONJUNCTIVAL HAEMORRHAGE –A RANDOMISED CONTROLLED CLINICAL TRIAL

DR ADEEB A1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年12月16日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
Kshaudraadi Aschyotana if proved effective will help in managing Arjuna (sub conjunctival haemorrhage)

研究概览

简要总结

The study is a randomized controlled clinical study to evaluate the Efficacy of kshaudradi aschyotana in sub conjunctival haemorrhage and to compare with flurbiprofen eye drops  for a period of 5 days. Study will be conducted in KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya and Research centre owned KLE Ayurveda Hospital Shahapur BELAGAVI Karnataka India . The expected outcome is to bring down all the symptoms to normalcy

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Irrespective of occupation, ocular diseases like refractive error, cataract, squint eyes, chalazion, entropion, ectropion, trichiasis, distichiasis, poliosis.
  • Idiopathic sub-conjunctival haemorrhages Traumatic sub-conjunctival haemorrhage without epithelial defect.

排除标准

  • Systemic disorders like DM, HTN, COPD, Renal pathologies Patients with iatrogenic sub-conjunctival haemorrhage (Post-operative) Vicarious bleeding associated with menstruation Patients with other common cause of red eye such as conjunctivitis, episcleritis and scleritis keratitis and corneal ulcer, iritis glaucoma and common condition such as dry eye and blepharitis were excluded.

结局指标

主要结局

Kshaudraadi Aschyotana if proved effective will help in managing Arjuna (sub conjunctival haemorrhage)

时间窗: 5days

次要结局

  • Kshaudradi Aschyotana may be effective in managing arjuna (sub conjunctival haemorrhage(5 days)

研究者

发起方
DR ADEEB A
申办方类型
Other [SELF SPONSORED PG DISSERTATION WORK]

研究点 (1)

Loading locations...

相似试验